Alpha Tau Medical Ltd. · Healthcare · Biotechnology
Scores & Status Key
AI Summary Scores: Intraday / Swing / Long scores are synthesized from multi-factor analysis for each timeframe. They summarize current conditions discussed in the report and do not constitute trading recommendations.
Intraday Trend Score: A 0–100 composite from the Trend Explorer™ analytics engine used for ranking and comparison. It describes current conditions and is not a forecast.
Trend Status: A rules-based label (Bullish / Mixed / Bearish) derived from signal confluence (trend structure, momentum, and positioning). It indicates alignment, not expected return.
Last
$7.76
−$0.17 (−2.14%) 4:00 PM ET
Prev closePrevC$7.93
OpenOpen$7.86
Day highHigh$7.88
Day lowLow$7.60
VolumeVol203,576
Avg volAvgVol376,756
On chart
Interval
Intervals apply to 1D & 5D.
Intervals apply to 1D & 5D.
Scale: Linear
Overlays
Panels
Style
Scale: Linear
Presets
Tools
Tickers only (no ^ indexes). Add up to 5.
Mkt cap
$661.65M
Sector
Healthcare
AI report sections
MIXED
DRTS
Alpha Tau Medical Ltd.
No AI report section text found yet for this symbol.
Volume vs average
Intraday (cumulative)
−34% (Below avg)
Vol/Avg: 0.66×
RSI
59.68(Neutral)
Neutral (40–60)
0255075100
MACD momentum
Intraday
+0.00 (Strong)
MACD: 0.01 Signal: 0.01
Short-Term
+0.01 (Strong)
MACD: 0.32 Signal: 0.31
Long-Term
-0.01 (Weak)
MACD: 0.76 Signal: 0.77
Intraday trend score
54.00
LOW34.00HIGH56.00
Latest news
DRTS•12 articles•Positive: 3Neutral: 0Negative: 0
PositiveGlobeNewswire Inc.• Alpha Tau Medical Ltd.
Alpha Tau to Present at the J.P. Morgan 2026 Healthcare Conference
Alpha Tau Medical will present a corporate overview and update at the J.P. Morgan 2026 Healthcare Conference on January 15, 2026, discussing recent achievements and upcoming data milestones for their Alpha DaRT cancer therapy.
Company is presenting at a major healthcare conference, highlighting recent patient treatments and research progress in cancer therapy
PositiveGlobeNewswire Inc.• N/A
Radiopharmaceuticals Market Products and Applications Report 2025 | SPECT Radiopharmaceuticals Lead Diagnostic Market with 67% Share
The global radiopharmaceuticals market is projected to grow at a CAGR of 10.3% from 2024 to 2030, driven by the increasing prevalence of chronic diseases, advancements in imaging technology, and the transition towards personalized medicine. North America and Asia-Pacific are the key regional markets.
The article lists the company as one of the key global players in the radiopharmaceuticals market, suggesting its strong presence and potential for growth.
PositiveGlobeNewswire Inc.• Globe Newswire
Alpha Tau Announces Appointment of Maya Netser to its Board of Directors; Board Member Meir Jakobsohn Stepping Down, Staying on as Advisor
Alpha Tau Medical Ltd. announced the appointment of Maya Netser to its Board of Directors, while Meir Jakobsohn is stepping down from the Board but will continue to serve as an advisor.
DRTSDRTSWAlpha Tau MedicalBoard of DirectorsMaya NetserMeir Jakobsohn
Sentiment note
The article announces the appointment of a new board member, Maya Netser, who is described as bringing a wealth of experience and a keen understanding of the industry. This suggests the company is taking steps to strengthen its leadership and position itself for future growth.
UnknownZacks Investment Research• Zacks Equity Research
New Strong Buy Stocks for January 8th
TIMB, AKYA, DRTS, TRUP and QSG have been added to the Zacks Rank #1 (Strong Buy) List on January 8, 2024.
TRUPTIMBAKYADRTS
UnknownBenzinga• Benzinga Insights
Expert Ratings for Alpha Tau Medical
Alpha Tau Medical (NASDAQ:DRTS) has observed the following analyst ratings within the last quarter:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
3
1
0
0
0
Last 30D
1
0
0
0
0
1M Ago
1
1
0
0
0
2M Ago
0
0
0
0
0
3M Ago
1
0
0
0
0
In the last 3 months, 4 analysts have offered 12-month price targets for Alpha Tau Medical. The company ...Full story available on Benzinga.com
DRTSAnalyst Ratings
UnknownZacks Investment Research• Zacks Equity Research
Down -20.29% in 4 Weeks, Here's Why You Should You Buy the Dip in Alpha Tau Medical Ltd. (DRTS)
Alpha Tau Medical Ltd. (DRTS) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
DRTS
UnknownBenzinga• Benzinga Insights
Analyst Ratings for Alpha Tau Medical
Within the last quarter, Alpha Tau Medical (NASDAQ:DRTS) has observed the following analyst ratings:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
2
2
0
0
0
Last 30D
0
1
0
0
0
1M Ago
0
0
0
0
0
2M Ago
1
0
0
0
0
3M Ago
1
1
0
0
0
According to 4 analyst offering 12-month price targets in the last 3 months, Alpha Tau Medical has ...Full story available on Benzinga.com
DRTSAnalyst Ratings
UnknownBenzinga• Lisa Levin
Why Alpha Tau Medical Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket
Gainers
Tivic Health Systems, Inc. (NASDAQ: TIVC) rose 62.4% to $3.15 in pre-market trading after falling 11% on Monday. Tivic Health Systems inked a pact to make its products available on AmerisourceBergen’s third-party marketplace.
Shineco, Inc. (NASDAQ: SISI) shares gained 50% to $0.2130 in pre-market trading after declining over 3% on Monday.
noco-noco Inc. (NASDAQ: NCNC) shares rose 44.5% to $2.89 in pre-market trading after falling 23% on Monday.
Caravelle International Group (NASDAQ: CACO) shares climbed 26.5% to $0.7087 in pre-market trading after falling 11% on Monday.
iCoreConnect Inc. (NASDAQ: ICCT) shares gained 23.8% to $1.97 in pre-market trading after dipping 20% on Monday.
Bright Scholar Education Holdings Limited (NYSE: BEDU) shares rose 14.7% to $1.01 in pre-market trading. Bright Scholar Education recently announced its unaudited financial results for ...
DRTSGNSHEICACONewsPenny StocksSmall CapPre-Market Outlook
UnknownZacks Investment Research• Zacks Equity Research
What's in Store for Patterson Companies (PDCO) in Q4 Earnings?
Patterson Companies' (PDCO) fiscal fourth-quarter results are likely to reflect an improvement at the Animal Health segment.
PDCOMMSIHQYDRTS
UnknownZacks Investment Research• Zacks Equity Research
Is a Beat Likely for Cooper Companies (COO) in Q2 Earnings?
Cooper Companies' (COO) fiscal second-quarter results are likely to reflect segmental strength.
COOSDCLVTXDRTS
UnknownZacks Investment Research• Zacks Equity Research
Should You Buy Alpha Tau Medical (DRTS) Ahead of Earnings?
Alpha Tau Medical (DRTS) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
DRTS
UnknownBenzinga• Benzinga Insights
Benzinga's Top Ratings Upgrades, Downgrades For April 24, 2023
Upgrades
For Medtronic PLC (NYSE:MDT), Barclays upgraded the previous rating of Equal-Weight to Overweight. Medtronic earned $1.30 in the third quarter, compared to $1.37 in the year-ago quarter. The stock has a 52-week-high of $114.22 and a 52-week-low of $75.77. At the end of the last trading period, Medtronic closed at $85.73.
Loop Capital upgraded the previous rating for Trex Co Inc (NYSE:TREX) from Hold to Buy. For the fourth quarter, Trex Co had an EPS of $0.23, compared to year-ago quarter EPS of $0.55. The stock has a 52-week-high of $67.69 and a 52-week-low of $38.73. At the end of the last trading period, Trex Co closed at $53.66.
According to Loop Capital, the prior rating for The AZEK Co Inc (NYSE:AZEK) was changed from Hold to Buy. In the first quarter, AZEK Co showed an EPS of $0.09, compared to $0.18 from the year-ago quarter. The stock has a 52-week-high of $30.26 and a 52-week-low of $15.15. At the end of the last trading period, AZEK Co closed at $26.70.
Janney Montgomery Scott upgraded the previous rating for Synovus Financial Corp (NYSE:SNV) from Neutral to Buy. For the first quarter, Synovus Finl had an EPS of $1.33, compared to year-ago quarter EPS of $1.08. At the moment, the stock has a 52-week-high of $48.60 and a 52-week-low of $27.08. Synovus Finl closed at $30.99 at the end of the last trading period.
For Healthpeak Properties Inc (NYSE:PEAK), Mizuho upgraded the previous rating of Neutral to Buy. Healthpeak Properties earned $0.44 in the fourth quarter, compared to $0.41 in the year-ago quarter. The current stock performance of Healthpeak Properties shows a 52-week-high of $35.71 and a 52-week-low of $20.21. Moreover, at the end of the last trading period, the closing price was at $21.13.
According to B of A Securities, the prior rating for Ally Financial Inc (NYSE:ALLY) was changed from Underperform to Neutral. For the first quarter, Ally Financial had an EPS of $0.82, compared to year-ago quarter EPS of $2.03. At the moment, the stock has a 52-week-high of $45.38 and a 52-week-low of $21.59. Ally Financial closed at $25.86 at the end of the last trading period.
According to Stifel, the prior rating for IDEAYA Biosciences Inc (NASDAQ:IDYA) was changed from Hold to Buy. For the fourth quarter, IDEAYA Biosciences had an EPS of $0.50, compared to year-ago quarter EPS of $0.47. At the moment, the stock has a 52-week-high of $19.13 and a 52-week-low of $8.14. IDEAYA Biosciences closed at $14.93 at the end of the last trading period.
According to Wells Fargo, the prior rating for Medtronic PLC (NYSE:MDT) was changed from Equal-Weight to Overweight. Medtronic earned $1.30 in the third quarter, compared to $1.37 in the year-ago quarter. The current stock performance of Medtronic shows a 52-week-high of $114.22 and a 52-week-low of $75.77. Moreover, at the end of the last trading period, the closing price was at $85.73.
According to Loop Capital, the prior rating for Alteryx Inc (NYSE:AYX) was changed from Hold to Buy. Alteryx earned $0.84 in the fourth quarter, compared to $0.17 in the year-ago quarter. The stock has a 52-week-high of $71.98 and a 52-week-low of $39.58. At the end of the last trading period, Alteryx closed at $52.13.
According to JP Morgan, the prior rating for PPG Industries Inc (NYSE:PPG) was changed from Neutral to Overweight. For the first quarter, PPG Indus had an EPS of $1.82, compared to year-ago quarter EPS of $1.37. At the moment, the stock has a 52-week-high of $145.14 and a 52-week-low of $107.06. PPG Indus closed at $141.98 at the end of the last trading period.
According to RBC Capital, the prior rating for Clearwater Paper Corp (NYSE:CLW) was changed from Sector Perform to Outperform. Clearwater Paper earned $0.30 in the fourth quarter, compared to $0.82 in the year-ago quarter. The stock has a 52-week-high of $46.40 and a 52-week-low of $26.21. At the end of the last trading period, Clearwater Paper closed at $32.67.
See all analyst ratings upgrades.
Downgrades
According to Exane BNP Paribas, the prior rating for Microsoft Corp (NASDAQ:MSFT) was changed from Outperform to Neutral. In the second quarter, Microsoft showed an EPS of $2.32, compared to $2.48 from the year-ago quarter. At the moment, the stock has a 52-week-high of $294.18 and a 52-week-low of $213.46. Microsoft closed at $285.76 at the end of the last trading period.
For First Solar Inc (NASDAQ:FSLR), Citigroup downgraded the previous rating of Neutral to Sell. For the fourth quarter, First Solar had an EPS of $0.07, compared to year-ago quarter EPS of $1.23. The current stock performance of First Solar shows a 52-week-high of $221.88 and a 52-week-low of $59.60. Moreover, at the end of the last trading period, the closing price was at $216.89.
Wedbush downgraded the previous rating for Offerpad Solutions Inc (NYSE:OPAD) from Outperform to Neutral. In the fourth quarter, Offerpad Solutions showed an EPS of $0.50, compared to $0.11 from the year-ago quarter. The current stock performance of Offerpad Solutions shows a 52-week-high of $5.87 and a 52-week-low of $0.38. Moreover, at the end of the last trading period, the closing price was at $0.47.
Wedbush downgraded the previous rating for Opendoor Technologies Inc (NASDAQ:OPEN) from Outperform to Neutral. For the fourth quarter, Opendoor Technologies had an EPS of $0.74, compared to year-ago quarter EPS of $0.13. At the moment, the stock has a 52-week-high of $8.37 and a 52-week-low of $0.92. Opendoor Technologies closed at $1.54 at the end of the last trading period.
Truist Securities downgraded the previous rating for Insperity Inc (NYSE:NSP) from Buy to Hold. In the fourth ...Full story available on Benzinga.com
News and sentiment labels describe article tone and are provided for research purposes only. They are not trading recommendations or forecasts.
Trade Ranks App
Trade Ranks, LLC is not a registered investment adviser or broker-dealer. All rankings and AI reports are for informational and educational purposes only and are not personalized advice. Investing involves risk. Policy Portal